
|Articles|September 1, 2003
Melanoma Fighter
Author(s)Andrew Bowser
Chicago - Arginine deiminase, an amino acid degrading enzyme, is safe and has anti-tumor activity in phase I and II investigations of metastatic melanoma, according to Theodore Logan, M.D.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
New Consensus Defines Remission, Disease Activity in Atopic Dermatitis
2
Real-World Study Finds Experienced Dermatologists Outperform AI in Skin Cancer Diagnosis
3
Beyond Retinol: Evaluating the Stability, Safety, and Gene-Expression Profile of Bakuchiol Ferulate
4
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
5












